Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Aichi
Clinical trial register · Japan

Clinical Trials in Aichi, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Japan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2493 matching records held by the registry are in this view. Synced 22 Oct 2026, 03:19 UTC
2493
Studies in scope
all four open statuses
1263
Recruiting now
open to new participants
349
Lead sponsors
across recruiting studies
Top sites
Fukuoka 551 Nagoya 517 Sapporo 398 Tokyo 369 Osaka 348
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Hoffmann-La Roche23 GlaxoSmithKline19 Novo Nordisk A/S10 Gilead Sciences6 Ono Pharmaceutical Co., Ltd.4
Site location
Fukuoka551 Nagoya517 Sapporo398 Tokyo369 Osaka348
All 926 locations
Target enrolment
to

Trials with a site in Aichi

103 of 2493 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Japan
Start
Recruiting
Novo Nordisk A/S
Phase 3
400
Sapporo, Yamato-shi, Chigasaki-shi, Kawasaki-shi, Suita-shi, Aichi, Bunkyo-ku, Tokyo, Chiba
2026-09-07
Active, closed
GlaxoSmithKline
Phase 3
102
Aichi, Chiba, Fukui, Fukuoka, Fukushima, Hokkaido, Kanagawa, Kyoto
2026-06-29
Recruiting
ViiV Healthcare
Phase 3
564
Aichi, Kanagawa, Osaka, Tokyo
2026-06-25
Recruiting
Taiho Pharmaceutical Co., Ltd.
Phase 3
784
Aichi, Fukuoka, Hokkaido, Kanagawa, Miyagi, Osaka, Tokyo, Toyama
2026-06-24
Recruiting
Hoffmann-La Roche
Phase 3
380
Toyohashi, Aichi, Ehime, Gunma, Hyōgo, Kyoto, Numakunai, Okayama
2026-06-23
Recruiting
GlaxoSmithKline
Phase 3
600
Aichi, Fukuoka, Hokkaido, Hyōgo, Kanagawa, Kyoto, Mie, Numakunai
2026-06-04
Recruiting
Aichi Medical University
Not applicable
90
Aichi, Gifu
2026-04-15
Recruiting
GlaxoSmithKline
Phase 2
200
Aichi, Chiba, Ehime, Fukushima, Gunma, Hokkaido, Ishikawa, Numakunai
2026-04-15
Recruiting
Hoffmann-La Roche
Phase 3
1,600
Aichi, Fukuoka, Hokkaido, Osaka, Tokyo
2026-03-23
Recruiting
Hoffmann-La Roche
Phase 3
2,000
Aichi, Fukuoka, Hokkaido, Osaka, Tokyo
2026-03-16
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Aichi, Bunkyō City, Chiba, Chūō, Fuchū, Fukuoka, Fukushima, Isehara
2026-03-05
Recruiting
Aichi Medical University
Not applicable
120
Aichi, Gifu
2025-11-20
Recruiting
Summit Therapeutics
Phase 3
600
Osaka, Aichi, Chiba, Ehime, Fukuoka, Gifu, Hiroshima, Hokkaido
2025-11-18
Recruiting
GlaxoSmithKline
Phase 2
363
Toyonaka-Shi, Aichi, Fukuoka, Hyōgo, Ibaraki, Ishikawa, Kanagawa, Mie
2025-10-30
Recruiting
Hoffmann-La Roche
Phase 3
600
Aichi, Fukuoka, Hokkaido, Hyōgo, Kagoshima, Kanagawa, Miyagi, Niigata
2025-10-24
Active, closed
GlaxoSmithKline
Phase 2
168
Aichi, Fukuoka, Hyōgo, Kumamoto, Okayama, Tokyo
2025-08-06
Not yet open
Encapsulation-oriented vs. Timing-oriented Strategies for Necrotizing Pancreatitis
NCT07106346Walled Off Necrosis, Pancreatitis, Acute Necrotic Collection, Necrotizing Pancreatitis
Tokyo University
Not applicable
224
Aichi, Chiba, Fukuoka, Gifu, Hokkaido, Hyōgo, Kagawa, Kagoshima
2025-08-05
Recruiting
Hoffmann-La Roche
Phase 3
80,000
Aichi, Hiroshima, Hyōgo, Kagawa, Kanagawa, Kochi, Kyoto, Meguro-Ku
2025-07-02
Recruiting
GlaxoSmithKline
Phase 1/2
346
Aichi, Chiba, Hokkaido, Osaka, Tokyo
2025-06-11
Recruiting
A Study of ONO-2020 in Patients With Agitation Associated With Alzheimer's Disease Dementia
NCT06803823Agitation Associated With Alzheimer's Disease Dementia
DrugONO-2020
Ono Pharmaceutical Co., Ltd.
Phase 2
90
Aichi, Akita, Aomori, Fukui, Fukuoka, Gunma, Hiroshima, Hokkaido
2025-05-01
Active, closed
Ono Pharmaceutical Co., Ltd.
Phase 2
260
Aichi, Chiba, Fukushima, Gunma, Hiroshima, Hyōgo, Ibaraki, Kagawa
2025-04-24
Recruiting
Novo Nordisk A/S
Observational
630
Koriyama-shi, Fukushima, Oita-shi, Oita,, Kumamoto, Aichi, Aomori, Chiba, Chitose, Hokkaido, Ehime
2025-04-15
Recruiting
Hoffmann-La Roche
Phase 3
450
Aichi, Chiba, Fukushima, Hiroshima, Hokkaido, Kanagawa, Okayama, Saitama
2025-04-09
Recruiting
Gilead Sciences
Phase 3
695
Aichi, Chiba, Ehime, Fukuoka, Hiroshima, Hyōgo, Kanagawa, Kobe
2025-04-04
Recruiting
Hoffmann-La Roche
Phase 3
600
Asahikawa-shi, Takamatsu, Sendai, Aichi, Aomori, Chiba, Chikushino-shi, Ehime
2025-03-17
Recruiting
Incyte Corporation
Phase 3
240
Aichi, Aichi-ken, Fukuoka, Hiroshima, Hyōgo, Isehara Kanagawa, Kumamoto Kumamoto, Maebashi
2025-01-21
Recruiting
Rakuten Medical, Inc.
Phase 3
412
Aichi, Hiroshima, Kyoto, Tokyo, Yonago
2024-12-24
Recruiting
GlaxoSmithKline
Phase 3
520
Shibuya-Ku, Aichi, Ehime, Fukuoka, Fukushima, Gunma, Hyōgo, Ibaraki
2024-12-16
Recruiting
GlaxoSmithKline
Phase 3
514
Aichi, Gunma, Hiroshima, Hokkaido, Tokushima, Tokyo, Yamanashi
2024-12-12
Recruiting
Novo Nordisk A/S
Phase 2
465
Koriyama-shi, Fukushima, Aichi, Ibaraki, Kanagawa, Kita-ku, Tokyo, Saitama, Sendai-shi, Miyagi, Siga
2024-12-02
Recruiting
GlaxoSmithKline
Phase 1
845
Aichi, Chiba, Shizuoka, Tokyo
2024-09-30
Recruiting
GlaxoSmithKline
Phase 3
440
Aichi, Fukuoka, Hiroshima, Hokkaido, Kanagawa, Miyagi, Miyazaki, Saitama
2024-09-11
Active, closed
Alpine Immune Sciences Inc, A Subsidiary of Vertex
Phase 3
605
Aichi, Amagasaki, Fukuoka, Itabashi-ku, Kahoku, Kanazawa, Kashihara, Kasugai
2024-08-30
Active, closed
Incyte Biosciences Japan GK
Phase 3
21
Aichi, Fukui, Fukuoka, Hiroshima, Hokkaido, Hyōgo, Kanagawa, Kumamoto
2024-07-30
Active, closed
Novo Nordisk A/S
Phase 3
10,000
Miyazaki, Aichi, Chiba, Ehime, Fukuoka, Fukuoka-shi, Fukuoka, Himeji-shi, Hyogo, Hokkaido
2024-06-25
Active, closed
Novo Nordisk A/S
Observational
1,071
Tokyo, Kumamoto, Aichi, Akita, Akita-shi, Akita, Aomori, Bunkyo-ku, Tokyo, Chiba
2024-06-11
Active, closed
GlaxoSmithKline
Phase 3
88
Aichi, Ehime, Fukuoka, Hokkaido, Hyōgo, Kyoto, Mie, Miyagi
2024-06-10
Active, closed
GlaxoSmithKline
Phase 2
41
Aichi, Chiba, Ehime, Fukuoka, Gunma, Hokkaido, Hyōgo, Ibaraki
2024-05-07
Active, closed
Servier Bio-Innovation LLC
Phase 1/2
61
Aichi, Ehime, Tokyo
2024-04-29
Recruiting
Eli Lilly and Company
Phase 3
510
Aichi, Chiba, Chūō, Fukui, Fukuoak, Fukuoka, Habikino-shi, Hirakata
2024-04-29
Active, closed
Gilead Sciences
Phase 3
577
Aichi, Osaka, Tokyo
2024-03-25
Recruiting
GlaxoSmithKline
Phase 3
864
Aichi, Aomori, Chiba, Ehime, Fukuoka, Gunma, Hokkaido, Hyōgo
2024-03-21
Recruiting
Verastem, Inc.
Phase 3
270
Tsu, Aichi, Miyagi, Osaka, Tokyo
2024-03-18
Recruiting
Zephyr Valve Japan Post-Marketing Surveillance
NCT06332885Emphysema, COPD, Severe Emphysema
Pulmonx Corporation
Observational
140
Aichi, Gifu, Kanagawa, Kanazawa, Kawasaki, Mie, Nagasaki, Nagoya
2024-03-12
Active, closed
ViiV Healthcare
Phase 3
463
Aichi, Osaka, Tokyo
2024-02-21
Active, closed
BioMarin Pharmaceutical
Phase 3
6
Hokkaido, Saitama, Aichi, Tokyo
2023-12-25
Active, closed
GlaxoSmithKline
Phase 2
316
Aichi, Chiba, Hyōgo, Osaka, Saitama, Shizuoka, Tokyo
2023-11-14
Not yet open
WONDER-02 Trial: Plastic Stent vs. Lumen-apposing Metal Stent for Pancreatic Pseudocysts
NCT06133023Pancreatic Fluid Collection, Pancreatitis, Pancreatic Pseudocyst
Tokyo University
Not applicable
80
Aichi, Bunkyō-Ku, Tokyo, Chiba, Fukuoka, Gifu, Hyōgo, Kagawa, Kagoshima
2023-11
Active, closed
Summit Therapeutics
Phase 3
1,600
Aichi, Fukuoka, Hirosaki, Hiroshima, Hokkaido, Kashihara, Matsumoto, Miyagi
2023-10-26
By invitation
Novo Nordisk A/S
Observational
200
Aichi, Aomori, Asahikawa, Hokkaido, Beppu-shi, Oita-ken, Chiba, Fukuoka, Fukuoka-shi, Fukuoka-ken, Fukuoka-shi, Fukuoka
2023-10-04
Active, closed
Hoffmann-La Roche
Phase 3
1,130
Aichi, Chiba, Fukuoka, Gifu, Hokkaido, Hyōgo, Kanagawa, Kyoto
2023-09-18
Active, closed
Hoffmann-La Roche
Phase 3
687
Aichi, Chiba, Ehime, Fukuoka, Hiroshima, Hokkaido, Ishikawa, Kanagawa
2023-09-14
Recruiting
Hoffmann-La Roche
Phase 3
230
Aichi, Chiba, Hiroshima, Kagoshima, Kanagawa, Kyoto, Matsuyama, Saitama
2023-09-08
Active, closed
Hoffmann-La Roche
Phase 3
459
Aichi, Aomori, Chiba, Chūō, Ehime, Fukuoka, Hiroshima, Hokkaido
2023-08-08
Recruiting
GlaxoSmithKline
Phase 3
892
Aichi, Chiba, Fukuoka, Hokkaido, Hyōgo, Ibaraki, Kanagawa, Kyoto
2023-08-01
Active, closed
Gilead Sciences
Phase 3
654
Aichi, Aoba-ku, Bunkyō City, Chiba, Chūōku, Ehime, Fukushima, Kagoshima
2023-05-08
Active, closed
Janssen Research & Development, LLC
Phase 3
20,284
Aichi, Bunkyō City, Chiba, Chikushino-shi, Fukuoka, Funabashi-shi, Gifu, Higashiibaraki-gun
2023-04-11
Active, closed
TEZSPIRE (Tezepelumab) Asthma Japan Post-Marketing Study (PMS)
NCT05729711Bronchial Asthma (Only the Patients With Severe or Intractable Bronchial Asthma Which Could Not be Controlled With the Existing Therapy)
AstraZeneca
Observational
416
Aichi, Akita, Aomori, Chiba, Fukui, Fukuoka, Gifu, Gunma
2023-04-04
Active, closed
A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A
NCT05685238Haemophilia A, Haemophilia A With Inhibitors
Novo Nordisk A/S
Phase 3
451
Aichi, Gunma, Nara, Saitama, Tochigi, Tokyo
2023-02-13
Active, closed
Bellus Health Inc. - a GSK company
Phase 3
997
Aichi, Akita, Chiba, Fukui, Fukuoka, Fukushima, Gifu, Hiroshima
2022-12-05
Active, closed
Novo Nordisk A/S
Phase 3
3,400
Sapporo, Suita-shi, Aichi, Chiba-shi, Chiba, Gunma, Kanagawa, Osaka, Saitama
2022-11-01
Active, closed
Hoffmann-La Roche
Phase 3
122
Aichi, Chiba, Fukuoka, Gifu, Hokkaido, Hyōgo, Kanagawa, Miyagi
2022-09-27
Active, closed
ONO-4059 Study in Patients With Steroid-resistant Pemphigus
NCT06696716Pemphigus, Steroid-resistant Pemphigus
DrugTirabrutinib
Ono Pharmaceutical Co., Ltd.
Phase 3
34
Aichi, Ehime, Fukuoka, Fukushima, Gunma, Hokkaido, Kagoshima, Kanagawa
2022-08-15
Active, closed
Genentech, Inc.
Phase 3
373
Aichi, Chiba, Ehime, Hiroshima, Hokkaido, Hyōgo, Ibaraki, Kanagawa
2022-08-03
Recruiting
Immediate Necrosectomy vs. Step-up Approach for Walled-off Necrosis
NCT05451901Pancreatic Fluid Collection, Walled-off Necrosis, Pancreatitis, Acute Necrotizing, Pancreatic Pseudocyst
Tokyo University
Not applicable
70
Bunkyō-Ku, Aichi, Chiba, Gifu, Hyōgo, Kagawa, Kagoshima, Kamogawa
2022-07-29
Active, closed
Gilead Sciences
Phase 3
443
Aichi, Aoba-ku, Bunkyō City, Chūōku, Ehime, Fukushima, Inamachi, Kagoshima
2022-07-25
Active, closed
Gilead Sciences
Phase 3
623
Aichi, Bunkyō City, Chūōku, Ehime, Kagoshima, Kashiwa, Kōtoku, Kumamoto
2022-07-20
Recruiting
Ono Pharmaceutical Co., Ltd.
Phase 3
15
Aichi, Fukuoka, Fukushima, Hiroshima, Hokkaido, Hyōgo, Ibaraki, Kagoshima
2022-07-12
Active, closed
Incyte Corporation
Phase 1
291
Aichi, Chiba-ken, Hidaka-shi, Tokyo
2022-07-05
Recruiting
AstraZeneca
Observational
300
Aichi, Akita, Aomori, Chiba, Ehime, Fukui, Fukuoka, Fukushima
2022-06-02
Active, closed
Precise Procedural and PCI Plan (P4)
NCT05253677Coronary Artery Disease
CoreAalst BV
Not applicable
1,090
Aichi
2022-04-01
Active, closed
AstraZeneca
Observational
1,620
Aichi, Akita, Aomori, Chiba, Ehime, Fukui, Fukuoka, Fukushima
2021-12-21
Active, closed
Hoffmann-La Roche
Phase 3
41
Aichi, Chibashi, Chibaken
2021-11-17
Active, closed
Hoffmann-La Roche
Phase 3
478
Aichi, Chiba, Kyoto, Mie, Miyagi, Okayama, Tokyo
2021-10-27
Active, closed
Hoffmann-La Roche
Phase 3
83
Aichi, Saitama, Tokyo
2021-10-22
Active, closed
Study of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors
NCT05101096Advanced Solid Tumor, Metastatic Triple-Negative Breast Cancer, HR+/HER2- Metastatic Breast Cancer, Metastatic Urothelial Cancer
DrugSacituzumab Govitecan
Gilead Sciences
Phase 1/2
135
Aichi, Akita, Aoba-ku, Aomori, Asahi-ku, Bunkyō City, Chiba, Chūōku
2021-10-20
Recruiting
Genentech, Inc.
Phase 1
186
Aichi, Okayama, Tokyo, Yamagata
2021-07-26
Active, closed
GlaxoSmithKline
Phase 3
40
Aichi, Chiba, Ehime, Fukuoka, Hiroshima, Hokkaido, Kagoshima, Kanagawa
2021-06-28
Recruiting
AB122 Platform Study
NCT04999761Advanced or Metastatic Solid Tumor, Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, Non-small Cell Lung Cancer
DrugsPimitespib·Futibatinib·Domvanalimab·Ramucirumab
Taiho Pharmaceutical Co., Ltd.
Phase 1
917
Aichi, Chiba, Ehime, Hokkaido, Kanagawa, Osaka, Shizuoka, Tokyo
2021-06-01
Active, closed
Hoffmann-La Roche
Phase 3
761
Aichi, Chiba, Ehime, Hiroshima, Hokkaido, Ibaraki, Kanagawa, Kyoto
2021-05-03
Active, closed
Hoffmann-La Roche
Phase 3
557
Aichi, Chiba, Fukuoka, Hiroshima, Hyōgo, Kanagawa, Osaka, Tochigi
2021-04-26
Recruiting
Boston Scientific Corporation
Observational
5,000
Sapporo, Kyoto, Miyazaki, Aichi, Chiba, Osaka
2021-03-29
Active, closed
Hoffmann-La Roche
Phase 3
342
Aichi, Chiba, Fukuoka, Hiroshima, Kanagawa, Osaka, Tokyo
2021-03-12
Active, closed
Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms
NCT04279847Myelofibrosis, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Neoplasm Overlap Syndrome, Myeloproliferative Neoplasm
DrugRuxolitinib
Incyte Corporation
Phase 1
140
Aichi, Chiba, Chūō, Fukuoka, Kumamoto
2021-02-23
Active, closed
Pullback Pressure Gradient (PPG) Global Registry
NCT04789317Chronic Coronary Insufficiency, Non ST Elevation Myocardial Infarction
VZW Cardiovascular Research Center Aalst
Observational
982
Aichi, Gifu, Tokyo
2020-12-23
Active, closed
Incyte Biosciences Japan GK
Phase 1/2
72
Aichi, Chiba, Fukui, Fukuoka, Hyōgo, Kanagawa, Kōtoku, Kumamoto-ken
2020-12-15
Active, closed
Hoffmann-La Roche
Phase 3
992
Aichi, Chiba, Fukuoka, Hiroshima, Hokkaido, Hyōgo, Ibaraki, Kagoshima
2020-10-09
Active, closed
GlaxoSmithKline
Phase 3
302
Aichi, Chiba, Ehime, Fukushima, Gunma, Hokkaido, Numakunai, Okayama
2020-10-01
Active, closed
Hoffmann-La Roche
Phase 3
190
Aichi, Hyōgo, Ishikawa, Kanagawa, Mie, Nagano, Nagasaki, Okayama
2020-09-30
Active, closed
Trial of the Safety and Efficacy of Epcoritamab in Japanese Subjects With Relapsed or Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (R/R B-NHL)
NCT04542824Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Primary Mediastinal Large B Cell Lymphoma, Follicular Lymphoma
DrugsRituximab and lenalidomide·Gemcitabine and oxaliplatin·Epcoritamab·Lenvatinib
Genmab
Phase 1/2
78
Sendai, Aichi, Chiba, Ehime, Fukuoka, Fukushima, Kagoshima, Kyoto
2020-08-20
Active, closed
GlaxoSmithKline
Phase 3
494
Aichi, Aomori, Ehime, Fukuoka, Gifu, Gunma, Hyōgo, Kanagawa
2020-05-07
Active, closed
GlaxoSmithKline
Phase 3
325
Shibuya-Ku, Aichi, Chiba, Ehime, Fukushima, Gifu, Gunma, Hokkaido
2020-04-02
Recruiting
Sumitomo Pharma America, Inc.
Phase 1/2
240
Aichi, Aomori, Chiba, Fukuoka, Hokkaido, Kamakura, Miyazaki, Okayama
2019-12-16
Active, closed
Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors
NCT04082429Haemophilia A Without Inhibitors, Haemophilia B Without Inhibitors
DrugConcizumab
Novo Nordisk A/S
Phase 3
156
Aichi, Hiroshima, Hyōgo, Niigata, Osaka, Saitama, Shizuoka, Tokyo
2019-11-13
Active, closed
Daiichi Sankyo
Phase 1/2
247
Aichi, Chiba, Hokkaido, Hyōgo, Kagawa, Osaka, Ōsaka-sayama, Saitama
2019-11-03
Active, closed
Novo Nordisk A/S
Phase 3
134
Aichi, Kagoshima, Kanagawa, Mie, Nara, Saitama, Tokyo
2019-10-21
Active, closed
Hoffmann-La Roche
Phase 3
1,000
Aichi, Ehime, Fukuoka, Hokkaido, Ibaraki, Ishikawa, Miyagi, Niigata
2019-02-28
Active, closed
Hoffmann-La Roche
Phase 3
257
Aichi, Chiba, Fukuoka, Hiroshima, Hokkaido, Hyōgo, Kanagawa, Kumamoto
2018-08-16
Active, closed
ViiV Healthcare
Phase 3
631
Aichi, Osaka, Tokyo
2016-10-27
Active, closed
Eisai Inc.
Phase 3
1,069
Aichi, Akita, Aomori, Chiba, Fukuoka, Hiroshima, Hokkaido, Hyōgo
2016-10-13
Active, closed
W.L.Gore & Associates
Not applicable
79
Aichi, Osaka, Ōita, Tokyo
2016-08
Recruiting
Quality of Pediatric Resuscitation in a Multicenter Collaborative
NCT02708134Cardiac Arrest, Cardiopulmonary Arrest
Children's Hospital of Philadelphia
Observational
7,000
Aichi, Kobe, Tokyo
2016-05-02
Active, closed
Hoffmann-La Roche
Phase 2
534
Aichi, Chūō, Hyōgo, Matsuyama, Miyagi, Niigata, Osaka, Shizuoka
2015-11-19
Rows per page Showing 1–103 of 103
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Japanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 October 2026. https://priyalifescience.com/clinical-trials-japan/city/aichi

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Japan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,493 studies in total at the last sync on 22 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 103 of those studies with a site in Aichi.

How many clinical trials are recruiting in Aichi?

42 of the 103 studies on this page are recruiting new participants as of the 22 Oct 2026, 03:19 UTC sync. A further 2 have not yet opened recruitment, 58 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Aichi), 103 studies
PhaseStudiesRecruitingShare
Phase 3652563.1%
Observational1059.7%
Phase 2948.7%
Not applicable736.8%
Phase 1/2726.8%
Phase 1534.9%

Most active sponsors

Lead sponsors with the most studies (Aichi)
Lead sponsorStudiesRecruiting
Hoffmann-La Roche238
GlaxoSmithKline1910
Novo Nordisk A/S103
Gilead Sciences61
Ono Pharmaceutical Co., Ltd.42
AstraZeneca31
Incyte Corporation31
Tokyo University31
ViiV Healthcare31
Aichi Medical University22
→

Other trial registries in Japan

This register lists Japan studies from ClinicalTrials.gov. Many studies in Japan are registered only in a national registry. We do not copy those records; search them directly:

  • jRCT (Japan Registry of Clinical Trials) — run by the Ministry of Health, Labour and Welfare; trials under Japan's Clinical Trials Act and other clinical research
  • UMIN-CTR — run by the University of Tokyo Hospital's UMIN Center; many academic and investigator-led studies
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.